| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  Archon Biosciences Pioneering next-generation antibody therapies with AI and computational protein design Archon is a biotechnology company developing computationally designed proteins to unlock powerful therapeutic targets that lie beyond the reach of existing modalities and to better treat disease. We directly apply generative protein design to create a new biologic class, Antibody Cages (AbCs), that integrates the industry-proven affinity and specificity of antibodies into self-assembling nanostructures. Precise control over AbC structure provides the ability to tune both how they distribute in the body and engage their cellular targets with high specificity and potency to establish a new gold-standard for biologic medicines. Archon … 61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 26 |
 |  1910 Genetics Advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation. 1910 Genetics is the only biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation. We integrate AI with three proprietary data streams – computational data, wet lab proxy biological data, and wet lab ground truth biological data – to deliver novel drug candidates and software solutions to leading pharma and tech partners, and advance our internal pipeline for neurological, autoimmune diseases, and cancer. We are backed by leading investors including M12 - Microsoft's Venture Fund, … 89 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Data Analytics Synthetic Biology | 2 | 33 |
 | Avenue Biosciences Transforming protein biologics with groundbreaking high-throughput protein engineering. Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biology and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, … 142 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 10 |
 | Integrated Biosciences, Inc. Unravelling complex biology with optogenetics, chemistry and computation for small molecule discovery. Our platform is built around a proprietary synthetic biology toolkit, featuring advanced optogenetic tools that enable precise temporal and spatial control of complex pathways and difficult-to-drug targets. Powered by vast proprietary datasets and cutting-edge AI models, our platform accelerates drug discovery and facilitates the generation of novel chemical matter, unlocking solutions for even the most challenging biological systems. biotechnology, aging, drug discovery, machine learning, synthetic biology, optogenetics, artificial intelligence, small molecule, rejuvenation, molecular biology, and novel therapeutics 203 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology A.I. - Machine Learning | 1 | 11 |
 | GRO Biosciences GRObio’s groundbreaking science expands the amino acid alphabet to deliver on the promise of protein-based therapies. GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases. Protein therapeutics, Biologics, and Genomic recoding 99 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 19 |
 | SMARTOX Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library 336 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 0 | 8 |
 |  DeepLife AI for digital twin of cells DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, … 91 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning SaaS | 22 | 29 |
 | Nuritas See Nature Differently Through pioneering life science and artificial intelligence, we developed our unique Nuritas MagnifierNπΦ platform that allows us to identify, unlock, clinically test and patent peptides; turning them into powerful and precise ingredients that elevate natural efficacy. We want to empower people to live healthier lives, naturally by making our everyday products healthier, safer, greener and more efficacious. From what we eat, to what we apply to our skin. By translating nature’s wisdom into innovation, together, we can change the life of billions. Pure peptides, Peptide mixtures, Hydrolysates, Multi targeted peptides, Bioinformatics, Artificial intelligence for drug discovery, Peptide … 58 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology | 23 | 58 |
 | Insilico Medicine #insilicomeds, #drugdiscovery, #ai, #GANs, #GANs-RL, #DL #aging, #longevity Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. artificial intelligence, deep learning, reinforcement learning, drug discovery, … 57 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning Generative A.I. Synthetic Biology | 21 | 279 |
 | Abtech Therapeutics Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible. 259 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 |
 | Ingenza Ltd ADVANCED BY NATURE. Ingenza Ltd. is a boutique, employee-owned CRDMO that develops smarter bioprocesses across life sciences and industrial biotech. With over two decades of experience, Ingenza combines molecular biology, biocatalysis, and computational design into a platform-based approach that enables predictable, scalable, and efficient biomanufacturing. At the heart of our offering are proprietary inGenius platform that drive decision-making and accelerate development: codABLETM – our machine learning-driven gene optimization tool for intelligent codon selection and expression tuning Rapid Strain and Cell Line Development – modular workflows for host selection, expression screening, and stability assessment Integrated Process Development – upstream and downstream … 125 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 51 |
 | BPGbio, Inc. #AI #biopharma #therapeutics #mitochondrial #proteinhomeostasis #oncology #neurology #raredisease #drugdiscovery BPGbio is a leading biology-first AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in late-stage clinical trials. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform, protected by over 400 US and international patents; one of the world’s largest clinically annotated non-governmental biobanks with longitudinal samples; and exclusive access to the most powerful supercomputer in the world. With these tools, BPGbio is redefining how patient biology can be … 82 similar entities Type: SMB Activities: biotech deeptech Technologies: A.I. Data Analytics Synthetic Biology | 12 | 68 |
 | Arzeda The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules Arzeda, The Protein Design CompanyTM, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. Synthetic Biology, Bio-based Chemicals, and Protein Design 95 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 68 |
 | Discovery Park A thriving life science community for entrepreneurs and leaders and the ideal environment for businesses to succeed 🧪 Discovery Park is the ideal environment for life science businesses to succeed. From state-of-the-art labs and offices to comprehensive support, we work in partnership with you to provide firm foundations for every stage of your growth. Within easy reach of London, our location provides access to a wealth of resources and opportunities with the freedom to expand, making it the optimal setting for brilliant minds to unlock the potential of scientific breakthroughs. Science, Technology, Manufacturing, Research , Research and Development, Enterprise, Logistics, … 75 similar entities Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 24 | 79 |
 | Ksilink Patient-based drug discovery We design and apply unique patient-based cellular assays for large-scale phenotypic screening, leaning on the power of AI-driven image analysis. Integrated from bed to bench and back to bed, we aim to generate most efficient first-in-class therapeutic molecules for next generation medicine. AI image and data analysis, biology, high content screening, high throughput screening, deep learning, assay development, patient stratification, pyschiatric disorders, and cardiac muscle 235 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Synthetic Biology | 4 | 22 |
 | GENEPEP - PEPTIDE Peptide Chemistry company for design, synthesis, stability studies and chemical optimisation (SAR studies)- CIR agrement PEPTIDES, PEPTIDE LIBRARIES AND PROTEINS Innovative chemistry for therapeutic, diagnostic and cosmetic applications GENEPEP is a CRO company (with CIR agreement) focused on peptide synthesis & services : - Tools for nanoparticles & surface functionalization - Custom synthesis of peptides, proteins & peptide libraries - Catalog of toxins, peptides & pseudopeptides - Design & synthesis for SAR studies (optimisation of solubility, stability, efficacy,...) - Stability & solubility tests - Partner of European programs, ANR, FUI etc... 375 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 14 |
 | Anima Biotech We believe the only way to discover better, life-changing drugs is by seeing diseases in action, not guessing them. That’s why at Anima Biotech, we’ve built the AI platform that thinks, sees, and learns biology at the core of disease mechanisms, inside real patient-derived cells. Anima Biotech is a TechBio pioneer, transforming target and drug discovery with Lightning.AI - the first Visual Biology loop where Computational and Experimental AI agents iteratively think, see, and learn disease pathways, turning the undruggable into tomorrow’s therapies. Lightning.AI runs two AIs in one discovery loop - Computational AI that thinks of thousands of hypotheses … 48 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I. | 5 | 67 |
 | Synthace Helping scientists solve the world's most pressing problems with faster, more powerful experiments. Synthace is a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress. It allows biologists to design, plan, and automate experiments in a single place, then automatically gather structured experiment data and metadata in a unified no-code environment. Biotech, Life Sciences, Software, Lab Automation, Bioprocessing, Engineering Biology, and Programming 52 similar entities Type: Startup Activities: biotech deeptech Technologies: SaaS | 19 | 42 |
 | Bioptimus We build foundation models that will transform biology. We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology. artificial intelligence, biology, and foundation models 58 similar entities Type: Startup Activities: biotech it services Technologies: Generative A.I. A.I. | 15 | 28 |
 | DiscoveryOrtho Partners A Technology Development and Advisory Company Focused on Medical Devices/Biologics Strategic Advisory Services for both large & small medical device/biologics companies including acquisition, licensing, distribution, joint venture agreements Market, Scientific and Clinical Due Diligence Services Business development Services for venture capital, private equity, hedge funds and investment banking clients & their portfolio companies and clients Product/Device development Strategic Product Postioning including licensing, distribtution and market positioning New Company Formation 520 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 2 |
 | Biotrains CONNECT COLLABORATE EVOLVE Biotrains is world's leading provider of business conferences, training, managed events and Consulting services for Pharmaceutical, Biotech, Healthcare and Medical Device industry. We at Biotrains recognize that knowledge is power and continuous learning is fundamental for the success of all business and academia. We deliver world-class content and expert knowledge that our clients demand to outshine in their professional roles giving a competitive advantage to their organization. We organize specialized technical events in areas including • Lyophilization/Freeze Drying • Bioprocess Development & Manufacturing • Drug Development, Drug Discovery • Diagnostics & Personalized Medicine • Healthcare, Home Healthcare … 81 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 33 |
 | BGene Genetics Believe in Nature, belong to Future BGene aims at developing sustainable and resilient production ways for high value added, biobased molecules. To this end, BGene develops expertise in domains such as molecular biology, microbiology, biochemistry, process engineering and computer sciences. Food and feed, pharma, cosmetics, chemistry, and environment are among the diverse markets that BGene can address thanks to the cutting-edge bioprocesses developed by BGene know-how. Strain engineering, Microorganism chromosome engineering, Synthetic Biology, Molecular Biology, Bioinformatics, Bioprocess, and Enzyme Engineering 69 similar entities Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials Synthetic Biology | 13 | 19 |
 | BionomeeX BionomeeX provides innovative analysis tools to support your biological, medical and environmental R&D projects. BionomeeX is a CNRS, and Univ. Montpellier spin off company. Our solutions include, at the same time, crafted algorithms and/or adapted computational solutions in a single package following your needs and demands. We also deploy our own software initially brewed in the academic world to provide solutions in biology, genetics, genomics... Biology, AI, and DeepLearning 34 similar entities Type: Startup Activities: deeptech it services Technologies: A.I. | 14 | 7 |
 | Zymvol Biomodeling Accelerating enzyme discovery and design through computer simulations We are a biotech company that delivers tailor-made enzymes designed to outperform client's needs. At Zymvol we combine cutting edge technology with top scientific expertise to make biocatalysis available to everyone. We are a trusted partner that supports our customers in every stage of their bio-journey: from project definition and prioritization to the development and delivery of tailored enzymes. Our unique approach enables unparalleled accuracy and predictability, along with unprecedented speed. We are the perfect partner for companies aiming to maximize their return on investment and meet their timelines in biocatalysis development. … 65 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 32 |
 | Proteus by Seqens Biocatalysis from Lab to Industrial Scale Protéus is a pioneer in protein engineering technologies, with now 20 years expertise in developing tailored enzymes and scaling-up biocatalytic processes. Proteus offers: - An exclusive and diversified microorganism collection (including micro-algae and thousands of bacteria and archaebacteria extremophiles strains) - 1,000 sequenced strains, combined with data mining tools, offering a unique pool of millions enzymes - Patented directed evolution technologies (EvoSightTM & L-ShufflingTM) to optimize enzymes performances - A multidisciplinary skilled team dedicated to custom bioprocess development for client’s applications - Seqens CDMO capabilities enabling large scale biocatalytic production of chemicals & pharmaceuticals … 91 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 24 |
 | Rosa Biotech Biosensing. Reimagined. Rosa Biotech is an AI-driven biosensing and diagnostics company based in Bristol. Our mission is to provide outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology. We have developed a novel sensing platform that leverages the rapid and precise approach honed over millions of years in the olfactory systems of mammals. By using machine learning we are capable of discriminating between complex biological samples and are able to predict commercial and clinical outcomes. Biosensing, Diagnostics, AI, Machine learning, Medicines manufacturing, Industrial biotechnology, Biotechnology, Biodesign, Chemistry, Protein design, Peptide design, Sensing, and Detection 42 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 0 | 3 |
 | Nostrum Biodiscovery Rethink and Accelerate Nostrum Biodiscovery is a spin-off from the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB), two of the most recognized Spanish international research centers. Nostrum Biodiscovery provide advanced technologies in Molecular Modelling, with two areas of focus : therapeutics, e.g. small molecules design, targeted protein degradation, antibodies, immunologics and nucleic acids, and bio-based chemistry as in enzyme engineering. Nostrum Biodiscovery’s customer-tailored solutions are based on state-of-the-art proprietary and 3rd-party software, combined with the latest development on AI. We use best in-class Molecular Modeling for data augmentation and fine-tuning of dedicated machine-learning algorithms. With … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 37 |
 | TAGC Understanding biological complexity, from genotype to phenotype, with interdisciplinary approaches. Our laboratory is a joint research unit of INSERM and the University of Aix-Marseille. We seek to decipher the complex biological mechanisms involved in the development or physiological functioning of an organism. Our research project is organized around two axes, one entitled "bioinformatics and genomics of molecular networks", the second "genetics and genomics of multifactorial diseases". We conduct not only basic research projects, but also collaborative projects with hospitals and biotech companies. This policy is fully in line with INSERM's strategic plan. Our ambition is both to contribute to a … 27 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 16 |
 | ResoTher Pharma Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry 662 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 17 |
 | Novalix Novalix is a premier drug discovery CRO Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, and Chemical process research 128 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 36 | 373 |
 | Cocoon Bioscience Proteins For Sustainability Cocoon Bioscience specializes in the manufacturing of high performance growth factors and enzymes using an automated platform leveraging cocooned insects as natural, low cost bioreactors. 173 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 41 |
 | CellVoyant We see the future in cells CellVoyant is an AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases. Our technology uses AI-first live cell imaging to predict and optimise stem cell differentiation, to controllably manufacture any cell and tissue in the body at scale. CellVoyant is built on foundational work from the Carazo Salas lab at the University of Bristol. We’re working at the exciting intersection of cell biology, computer vision, engineering, and machine learning to industrialise next-generation science from research into the real world. Our mission is bold and ambitious and we have … 71 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology | 4 | 17 |
 | Cellarity Rewriting the rules of drug creation Cellarity is fundamentally redesigning the way drugs are created. By shifting the focus from a single target to the underlying cellular dysfunction, the company unravels the complexity of disease biology to create medicines that are out of reach with the target-based drug discovery approach. Founded by Flagship Pioneering in 2017, Cellarity has developed a platform that utilizes proprietary AI models trained on over 30 million single cell transcriptomes to uncover novel actionable biology and create non-intuitive drug candidates in a vast array of diseases. The company currently has programs ongoing in several disease areas … 281 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology | 4 | 104 |
 | Bitome Better tools, faster science Bitome is a Boston-based life sciences tools company that uses metabolomic insights to drive efficient biomanufacturing. Bitome's magnetic-resonance/neural-network-driven platform provides quantified analysis of the cell culture environment -- enabling bio-based products to get to market faster. Our mission at Bitome is to enable the bioeconomy with purpose made tools, so join us as we de-risk industrial biology. Magnetic Resonance, synthetic biology, continuous monitoring, metabolic analysis, lab automation, instrumentation, MEMS, microfluidics, and machine learning Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Bio sourced materials Synthetic Biology | 0 | 1 |
 | Sentinal4D 3D cell shape + AI to bring the right therapies to the right patients sooner Sentinal4D is an AI-powered cancer drug discovery and development company, with close ties to the Institute of Cancer Research. Sentinal4D represents a collaboration of physics, biology and artificial intelligence to drive novel cancer therapy candidates with a high probability of clinical success. Artificial Intelligence, Computer Vision, Systems Biology, and Drug Discovery 108 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology | 0 | 4 |
 | LenioBio Rapid eukaryotic, cell-free protein expression that scales for research, development and production. At LenioBio, we develop efficient, robust and sustainable technologies to disrupt the way medicines and food are produced for those in need, wherever they are. Unconstrained by the limitations of cells, we combine our proprietary protein technology with machine learning to significantly accelerate innovation cycles in life science industry. Protein Expression, Protein Production, Synthetic Biology, Biotechnology, Membrane proteins, Antibodies, Functional Proteins, Sustainable Foods, Vaccines, Therapeutic Proteins, Structural Biology, Cell-free protein production, Cell-free protein expression, and Plant-based protein 138 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: A.I. A.I. - Machine Learning Bio sourced materials Synthetic Biology | 7 | 49 |
 | Harness Therapeutics Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases neurodegeneration, RNA therapeutics, physiological upregulation, post-transcriptional upregulation, mRNA, ASO, and SINEUP 279 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 32 |
 | Latent Labs Frontier models for all molecules of life. We are making biology programmable to transform health and sustainability for the benefit of all. We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering. Contact us to work with us today. 53 similar entities Type: Startup Activities: biotech healthtech deeptech Technologies: A.I. Generative A.I. | 2 | 15 |
 | MedFacts Drug discovery with cutting-edge AI technology We’re pioneering the use of AI and shaping the future in drug discovery, significantly cutting costs and development times. Our unique AI algorithms have generated novel drug candidates and identified enhancements for existing therapies more efficiently than traditional methods, setting us apart in the competitive landscape. Artificial Intelligence, Data Science, Health, Medicines, and Drug development 146 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 1 |
 | InVirtuoLabs Unlocking a bold new world of transformative drug discovery InVirtuoLabs is a new-generation laboratory for drug discovery. We design novel drugs by combining advanced machine learning techniques with physics-based simulations to rapidly identify and optimize promising drug candidates. 87 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 1 | 11 |
 | Cyclica (acquired by Recursion, Nasdaq: RXRX) From molecule to medicine Unlocking the protein universe to discover the medicines of tomorrow Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter. Drug Development, Network Pharmacology, Drug Repositioning, Proteomics, Clinical Trials, Side Effects, Bioinformatics, Systems Biology, Drug Discovery, Artificial Intelligence, polypharmacology, medicines, Machine learning, pharmacology, pharmaceuticals, and bioinformatics 71 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. A.I. - Machine Learning | 20 | 4 |
 | De Novo Foodlabs Advancing what’s next in nutrition De Novo Foodlabs is a pioneering biotech start-up revolutionising the field of nutrition. Leveraging the power of microbial fermentation, the company creates innovative products that promote better health for both people and the planet. Food design, Product Development, Recombinant proteins, nutrition, health, and alternativeproteins 215 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 1 | 10 |
 | New Wave Biotech Unleashing biotech innovation for a greener and fairer future For those creating a more sustainable future with biotechnology, we use AI and computational modelling to help precision fermentation alt protein companies optimise their downstream processing, so they can de-risk their ventures, speed up R&D and reduce costs. Biotechnology, Bioprocessing, Biomanufacturing, Precision Fermetation, ClimateTech, Alternative Protein, Computational Modelling, and Downstream Processing 188 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology | 14 | 10 |
 | Pencil Biosciences Limited Developing the Next Generation Gene Editing Technology Pencil Biosciences is developing a truly innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Genome Engineering, Research and Development, and Gene Editing 299 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 15 |
 | Reshape Biotech Accelerating the pace of R&D. Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x. The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team. We’re a fast growing startup with an incredibly ambitious team, dead-set on reinventing … 63 similar entities Type: Startup Activities: deeptech biotech Technologies: Robotics | 3 | 73 |
 | AMPLY Discovery Novel Biologics. Designed by Evolution. Discovered by AI. Novel Biologics. Designed by Evolution. Discovered by AI. AMPLY Discovery uses machine learning and synthetic biology to mine vast biological data to discover novel biologic drug and nutraceutical candidates. Using a proprietary in silico and in vitro hybrid platform to discover best-in-class molecules AMPLY is helping tackle some of humankind's greatest challenges such as cancer, MDR infections and metabolic diseases. Based in Belfast, Northern Ireland. Spin out from Queen's University Belfast. Biotechnology, Anti-infectives, Drug Discovery, AI, Machine Learning, Animal Health, Healthcare, Genomics, Metagenomics, Cancer, Biologics, Metabolic Diseases, Natural Drugs, Nutraceuticals, and Bioinformatics 63 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology A.I. - Machine Learning | 2 | 7 |
 | HEDERA-22 Intelligent Natural Product Discovery Platform. Hedera-22 is dedicated to unveiling novel natural products to address critical gaps in agriculture markets. Our focus involves creating an advanced natural product discovery platform, utilizing DNA-based synthesis and exclusive predictive bioinformatics. This innovative approach streamlines discovery, enhancing output, diversity, and compound maturity. Our extensive molecule library is open for screening, inviting opportunities for licensing or partnerships. Committed to contributing to a sustainable planet, our goal is to develop environmentally friendly products for crop protection, fostering a greener and more resilient future. Next Generation Biomolecules, Predictive approaches, Synthetic biology, Bio-informatics, Natural Products Discovery, AI, and … 38 similar entities Type: Startup Activities: deeptech Technologies: A.I. Synthetic Biology | 2 | 9 |
 | Amino Labs Make with Biology Amino Labs' mission is to make biotechnology learning and innovation accessible to teenagers, educators, and adults. Youtube: https://www.youtube.com/c/AminoLabs Education, Genetic Engineering, STEM, Hands-on Experiments, Zero to Genetic Engineering Hero, biology kits, STEAM, and science education 71 similar entities Type: Startup Activities: deeptech industry 4.0 Technologies: Synthetic Biology | 3 | 2 |
 | AUM Biosciences Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance biotech, oncology, drug development, Asian-biotech, Precision medicine, Digitalhealth, cancer, and small molecules 550 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 17 |
 | Unicorn Biotechnologies Liberating scientists & scaling cell biology Today, biologists spend too much time performing tedious manual tasks. Biologists should spend time on what they're exceptional at: pushing the frontiers of science and creating new medicines and products. We build intelligent machines that decouple biology from manual labor. This accelerates research and provides clear paths to scaling innovations from the lab bench to the factory floor. 72 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 11 |
 | Arctoris Arctoris is a tech-enabled Contract Research Organization (CRO) headquartered in Oxford, UK. Arctoris is a tech-enabled Partnership Research Organization (PRO) headquartered in Oxford. We combine our unique automation platform, Ulysses, with a world-class team of excellent laboratory scientists to guide and rapidly progress our partners’ drug discovery programs from target to candidate. Data is the lifeblood of research, and “Better Data leads to Better Decisions”. Our excellent service is built on: 1) Data quality: generating large reproducible datasets by leveraging robotics and wet lab automation, in turn empowering improved decision-making. 2) Our world-class team of experienced scientists: a true partner … 52 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology A.I. - Machine Learning | 9 | 34 |
 | M2Bio Sciences, Inc. M2Bio Sciences is a pioneering nutraceutical biotech company. Trading on the OTC: $MRES M2Bio Sciences is a pioneering nutraceutical biotechnology company that delves into the innovative realm of plant-based medicines, healthy food products, and sustainable packaging solutions. A distinctive feature of M2Bio Sciences is its divisional structure, each focusing on a specific wellness and sustainability aspect. It is committed to improving both human health and the planet's health. Ethically and sustainably sourced products are central to its mission, reflecting a deep-rooted concern for environmental sustainability. The Company employs cutting-edge artificial intelligence to power its endeavours. Medicine, Biotechnology, Health , Neuroscience, … 41 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. | 5 | 9 |
 | Peptone Drugging disordered proteins with physics and AI Peptone is a therapeutics company that uses AI and an experimental physics product engine to design small molecules targeting the 6,200 intrinsically disordered human proteins that Alpha Fold 3 cannot model. artificial intelligence, structural biology, high performance computing, supercomputers, biotechnology, and intrinsically disordered proteins 142 similar entities Type: Startup Activities: biotech deeptech it services Technologies: Synthetic Biology | 46 | 41 |
 | Emedgene, an Illumina Company Unlock genomic insights Emedgene is on a mission to unlock genomic insights for the world’s health organizations by providing data-driven AI solutions for genomic diagnostics and discovery at scale. We work with leading healthcare and life sciences organizations to enable precision medicine programs, enable high throughput diagnostics and accelerate the pace of research. Genomics, Human Genetics, Big Data, and Algorithms 155 similar entities Type: Startup Activities: biotech deeptech it services Technologies: A.I. A.I. - Machine Learning | 3 | 12 |
 | Ginkgo Bioworks, Inc. Making biology easier to engineer. At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to design, develop, and optimize products for a breadth of commercial applications. We help our partners grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more. We know our unique experiences, ideas, and perspectives are essential to our success and enable us to make biology easier to engineer and ensure equitable distribution of the benefits of our … 73 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology SaaS | 15 | 930 |
 | Selvita Integrated Drug Discovery | Drug Development | Contract Research Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. biotechnology, pharmaceuticals, drug discovery, preclinical research, bioanalytical development services, bioinformatics, systems biology, proteins, genomics, proteomics, autoimmune disorders, regulatory studies, medicinal chemistry, agrochemical, industrial chemistry, and assay development&screening 504 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 771 |
 | Computomics AI Technology for Growth We are Computomics - a biotech company enabling customers to reap the benefits of our advanced machine learning algorithms. By applying AI to genetics, phenotype, microbiome, and environmental datasets, we unlock the diversity of biological life. Computomics is a team of world-leading experts in machine learning, plant research and bioinformatics. In over 180 projects, we enabled our customers to make data-driven decisions and thereby accelerate sustainable agricultural development that can feed the world. Our advanced machine learning methods enable rapid understanding of genomic data for plant breeding, agricultural, biotech, and microbiome researchers. Computomics has its headquarters … 10 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Data Analytics | 9 | 32 |
 | Instituto de Biología Molecular y Celular de Plantas, IBMCP (UPV - CSIC) Discovering from Green - Scientific research aimed at obtaining plants with better productivity, fruit quality or with high -value added properties (of interest to the consumer, farmers and the agri -food industry) and more stress resistant, as well as less dependent on chemical treatments, in order to contribute to less aggressive agriculture with the environment. - Advanced genomics, proteomic, metabolomic, bioinformatics, microscopy, quantification of plant hormones, DNA sequencing and gene expression analysis. - Training of research personnel. Biotechnology, Molecular Biology, Genomic, Proteomic, Bioinformatics, Metabolomics, Systems Biology, and Synthetic Biology 251 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 194 |
 | Nagi Bioscience in vivo testing at the in vitro scale At Nagi Bioscience, we develop cutting-edge biological testing solutions enabling scientists to generate the insights they need to fuel life-changing discoveries in a faster, more efficient, and ethical way. Our pioneering Organism-on-Chip platform, SydLabTM One, seamlessly integrates into existing lab environments, enabling scientists to enhance efficiency, accuracy, and reproducibility like never before. By combining this innovative technology with our team’s expertise, we deliver customer-focused solutions that empower scientists to advance research and drive scientific thinking forward. #inwormwetrust Microfluidic technology, Drug Screening, Pre-clinical studies, Lab Automation Technology, Safety and Efficacy, Toxicology, AI, C. … 184 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 42 |
 | UNIVERCELLS For humanity to thrive, we need transformative thinking in how vaccines and therapeutics are designed and produced. At Univercells, we believe in the power of small adaptations to drive big change. We embrace the spirit of evolution in everything we do. We are biotech innovators. We are scientists and entrepreneurs creating transformative platforms for the pharmaceutical and biotech industry, through technology, bioprocess know-how and entrepreneurial spirit. Biotechnology, mRNA, CDMO, and Services 88 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology | 4 | 128 |
 | BigHat Biosciences BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids … 62 similar entities Type: Startup Activities: biotech deeptech it services Technologies: A.I. Synthetic Biology SaaS Generative A.I. | 20 | 110 |
 | Ranomics Ranomics offers innovative solutions for protein engineering, drug discovery, genomics research and synthetic biology Ranomics offers high throughput solutions for protein engineering, drug discovery, genomics research and synthetic biology. Using our VariantFind and VERG genomics platforms, Ranomics offers partners the a scalable solution to engineer and screen genetic variants in a wide range of model organisms. Our industry leading DNA Variant libraries and high-throughput cell assays help researchers to hit their research objectives faster and with better results than traditional methods. Over the years, we have worked with top biotech and pharma companies in the US and worldwide. Our partners … 186 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 5 |
 | Atomic AI Rational design of new molecules and medicines, enabled by the fusion of artificial intelligence and structural biology. Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research featured on the cover of Science (doi.org/10.1126/science.abe5650), provides new strategies to treat or cure previously-undruggable diseases by targeting RNA structure. We are an interdisciplinary team working across computational and experimental biology and believe that our strongest asset is our people. We're hiring! https://boards.greenhouse.io/atomai 22 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology Generative A.I. | 2 | 35 |
 | Redesign Science Biology Simulated Founded in 2017, Redesign Science is a platform biotech working at the interface of physics-based molecular simulation and deep learning to create generative AI for drug discovery. We deploy our platform technology to develop first-in-class Protein Interaction Modulators against validated targets known to drive progression of multiple oncogenic and inflammatory diseases. 62 similar entities Type: Startup Activities: biotech deeptech Technologies: Generative A.I. A.I. Synthetic Biology A.I. - Deep Learning | 0 | 8 |
 | Profluent Grounded in nature, authored by AI Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Emeryville, CA, we are backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, AIX Ventures, and Convergent Ventures. To learn more about our mission to decode the language of life with AI, visit profluent.bio. artificial intelligence, machine learning, biotech, and gene editing 69 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology A.I. - Machine Learning Generative A.I. | 3 | 34 |
 | PartitionBio Ltd Exploiting a proprietary tech platform to develop biomolecular tools for therapeutic & synthetic biology applications PartitionBio Exploiting a novel proprietary technology platform to develop biomolecular tools for the use in therapeutic and synthetic biology applications. contact@partitionbio.co.uk 328 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 13 |
 | Recursion Decoding Biology to Radically Improve Lives We are a clinical-stage TechBio company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. We are leveraging new technology to create virtuous cycles of learning around datasets to build the next-generation biopharmaceutical company. It’s complex biology, decoded. While we are united in a common mission, Decoding Biology to Radically Improve Lives, our greatest strength lies in our differences: expertise, gender, race, disciplines, experience, and perspectives. Deliberately building and cultivating this culture is critical to achieving our audacious goals. We are proudly headquartered in Salt … 67 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 26 | 942 |
 | ApexQubit ApexQubit is a biotechnology company that is harnessing frontier technologies for better health for humanity. ApexQubit is a biotechnology company that is harnessing frontier technologies for discovery of new medicines and better health for humanity. https://www.apexqubit.com/ #ArtificialIntelligence #BioTech #DeepTech #QuantumComputing #FrontierTech #B2B #Startup #RNA #DrugDesign #HealthTech Artificial Intelligence, Quantum Computing, Quantum Machine Learning, DeepTech, FrontierTech, BioTech, and Therapeutics 63 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning | 0 | 2 |
 | Dante Omics AI The multiomics information company, specialist in whole genome sequencing and interpretation. Owner of Dante Labs. Dante Omics AI merges multiomics data with advanced artificial intelligence to drive innovation in precision medicine. The company leverages its proprietary Dante Platform to provide superior results to clinicians, researchers and individuals. The company continues to pioneer cutting-edge technologies that deepen our understanding of human biology and empower transformative healthcare solutions worldwide. genomics, AI, GenAI, omics, multiomics, longevity, DNA Tests, genomics, transcriptomics, proteomics, and spatial 60 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Generative A.I. | 7 | 85 |
 | Absci Creating Drugs at the Speed of Ai Absci is a data-first AI drug creation company designing differentiated therapeutics using generative AI. Our Integrated Drug Creation platform powers cutting-edge de novo AI models and AI lead optimization models aimed at designing better biologics against difficult-to-drug targets. generative AI, synthetic biology, biologics, drug discovery, antibody development, artificial intelligence, pharmaceuticals, and biotechnology 80 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning Generative A.I. Synthetic Biology | 11 | 188 |
 | Fraunhofer Institute for Interfacial Engineering and Biotechnology We combine biology and engineering The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB develops and optimizes processes, technologies, and products for health, sustainable chemistry and the environment. In doing so, we rely on the unique combination of expertise in biology and the engineering sciences in order to contribute to human welfare, a sustainable economy, and an intact environment with the systems approach of bioeconomy as well as bioinspired, biointegrated and biointelligent solutions. Working closely with partners from universities and industry, the IGB covers the entire innovation chain from fundamental research to industrial implementation. We provide our customers with research … 60 similar entities Type: SMB Activities: deeptech biotech Technologies: New Materials Synthetic Biology | 13 | 218 |
 | Deep Space Biology Artificial Intelligence Bridging Space and Earth for Human Health Discoveries. Deep Space Biology is the 1st company in the world to bridge both space and earth biological discoveries aimed to improve human health and increase life longevity. We created Yotta, the 1st AI driven platform that processes multi-omic data types from any living entity and reduces research time from years to minutes. Yotta’s predictive ability allows researchers to formulate more informed hypotheses and enhance drug discovery by accelerating the development of countermeasures. Space, Health, Pharma, Technology, and Genetics 16 similar entities Type: Startup Activities: spacetech biotech deeptech Technologies: A.I. | 4 | 9 |
 | Cradle Design better proteins. We believe Cells can theoretically produce almost anything, from fabrics to food, fuel and medicines. Designing cell-factories is hard, but our tools and machine-learning models can make it easier. Our mission is to ultimately help replace traditional farms and factories for a more sustainable world. Jobs: https://jobs.cradle.bio protein design, machine learning, protein activity, protein stability, protein secretability, protein , protein structure, metabolic engineering, protein engineering, and protein solubility 79 similar entities Type: Startup Activities: biotech Technologies: Synthetic Biology | 4 | 75 |